Group One Trading’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Group One Trading’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-23,700	Closed	-$11K	–	5551
2015 Q3	$11K	Buy	23,700 +1,100	+5%	+$629	﹤0.01%	4284
2015 Q2	$11K	Sell	22,600 -49,500	-69%	-$33.6K	﹤0.01%	4274
2015 Q1	$53K	Buy	+72,100	New	+$46.3K	﹤0.01%	3336
2014 Q4	–	Sell	-1,400	Closed	-$1K	–	5694
2014 Q3	$1K	Sell	1,400 -65,800	-98%	-$83.3K	﹤0.01%	5055
2014 Q2	$87K	Sell	67,200 -107,000	-61%	-$153K	﹤0.01%	3129
2014 Q1	$315K	Buy	174,200 +157,300	+931%	+$266K	0.01%	2052
2013 Q4	$26K	Sell	16,900 -40,700	-71%	-$91.7K	﹤0.01%	4115
2013 Q3	$141K	Sell	57,600 -143,700	-71%	-$398K	﹤0.01%	2708
2013 Q2	$580K	Buy	+201,300	New	+$557K	0.01%	1222

Other funds holding ONCY

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

KWMG

King Wealth Management Group Naples, Florida $800M AUM 22.41% 1-Year Est. Return

Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Group One Trading's ONCY Position: Q4 2015 in Review

Group One Trading sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 38,529 shares — an estimated $18K sold.

Group One Trading first reported a position in ONCY in Q2 2013 and held it in 7 quarters. The position peaked at $109K in Q2 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

Group One Trading reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
Group One Trading sold 38,529 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $18K.
Group One Trading first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 7 quarters.
Group One Trading's ONCOLYTICS BIOTECH INC position peaked at $109K in Q2 2013.
7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Group One Trading's 13F filing for Q4 2015, filed 11 Feb 2016.